Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Study on the Molecular Mechanism of Berberine to Improve Type 2 Diabetes Mellitus Complicated With Depression
Read the official source — NCT06979440Study on the Molecular Mechanism of Berberine Regulating the Gut Microbiota-derived Metabolites 5-AVAB to Improve Type 2 Diabetes Mellitus Complicated With Depression.
Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
Read the official source — NCT07139171Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
Study on the Use of Exergames to Support Older Adults With Psychosis
Read the official source — NCT07060742Feasibility of Exergame-based Cognitive-motor Training in Older Psychotic Inpatients: a Randomized Controlled Trial
Study on Therapeutic Mechanism of Natural Psychotherapy for Neurosis
Read the official source — NCT06443125This study assesses thinking abilities.
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
Read the official source — NCT06846320This study evaluates the safety and effectiveness of ABBV-932 for people with anxiety.
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Read the official source — NCT06786624This study evaluates the safety and effectiveness of NBI-1065845 for people with depression.
Researchers are comparing GXV813 and placebo to find out how the approaches affect psychotic symptoms in adults with schizophrenia.
Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder
Read the official source — NCT06538558A Phase I, Single-Center, Single-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Pharmacokinetics and Efficacy of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder
This study evaluates the effectiveness of Roluperidone for people with schizophrenia.
A Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate the Antipsychotic Efficacy and Safety of LB 102 in the Treatment of Adult Patients With Acute Schizophrenia
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
Read the official source — NCT06088121Effects of a ATNC MDD-V1 (TMS With Cognitive Training), for the Treatment of Mild Alzheimer Disease: a Randomized, Double-blinded, Placebo-controlled Study
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.